Cardioprotection in Right Heart Failure

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 2020 Jan 30

PMID 31995639

Citations 8

Authors

Kerstin Boengler

Klaus-Dieter Schluter

Ralph Theo Schermuly

Rainer Schulz

Affiliations

Soon will be listed here.

Abstract

Ischaemic and pharmacological conditioning of the left ventricle is mediated by the activation of signalling cascades, which finally converge at the mitochondria and reduce ischaemia/reperfusion (I/R) injury. Whereas the molecular mechanisms of conditioning in the left ventricle are well characterized, cardioprotection of the right ventricle is principally feasible but less established. Similar to what is known for the left ventricle, a dysregulation in signalling pathways seems to play a role in I/R injury of the healthy and failing right ventricle and in the ability/inability of the right ventricle to respond to a conditioning stimulus. The maintenance of mitochondrial function seems to be crucial in both ventricles to reduce I/R injury. As far as currently known, similar molecular mechanisms mediate ischaemic and pharmacological preconditioning in the left and right ventricles. However, the two ventricles seem to respond differently towards exercise-induced preconditioning. LINKED ARTICLES: This article is part of a themed issue on Risk factors, comorbidities, and comedications in cardioprotection. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v177.23/issuetoc.

Citing Articles

Connexin43, A Promising Target to Reduce Cardiac Arrhythmia Burden in Pulmonary Arterial Hypertension.

Sykora M, Szeiffova Bacova B, Andelova K, Benova T, Martiskova A, Kurahara L Int J Mol Sci. 2024; 25(6).

PMID: 38542257 PMC: 10970272. DOI: 10.3390/ijms25063275.

Ventricular differences in mitochondrial Ca dynamics in murine and porcine hearts.

Sung J, Chapoy Villanueva H, Feng F, Araque Igualador A, Prins K, Liu J J Mol Cell Cardiol. 2023; 182:54-56.

PMID: 37454413 PMC: 10774910. DOI: 10.1016/j.yjmcc.2023.07.006.

The mitophagy receptor FUN14 domain-containing 1 (FUNDC1): A promising biomarker and potential therapeutic target of human diseases.

Zhang W Genes Dis. 2021; 8(5):640-654.

PMID: 34291135 PMC: 8278526. DOI: 10.1016/j.gendis.2020.08.011.

Mitochondrial Monoamine Oxidase: Another Player in Pulmonary Hypertension?.

Sommer N, Schulz R Am J Respir Cell Mol Biol. 2020; 64(3):277-278.

PMID: 33321051 PMC: 7909332. DOI: 10.1165/rcmb.2020-0523ED.

Risk factors, co-morbidities, and co-medications in cardioprotection: Importance for translation.

Schulz R, Andreadou I, Hausenloy D, Ferdinandy P Br J Pharmacol. 2020; 177(23):5249-5251.

PMID: 33219717 PMC: 7679999. DOI: 10.1111/bph.15294.

References

Heusch G . Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. Circ Res. 2015; 116(4):674-99. DOI: 10.1161/CIRCRESAHA.116.305348. View

Boengler K, Ruiz-Meana M, Gent S, Ungefug E, Soetkamp D, Miro-Casas E . Mitochondrial connexin 43 impacts on respiratory complex I activity and mitochondrial oxygen consumption. J Cell Mol Med. 2012; 16(8):1649-55. PMC: 3822677. DOI: 10.1111/j.1582-4934.2011.01516.x. View

Zhai C, Shi W, Feng W, Zhu Y, Wang J, Li S . Activation of AMPK prevents monocrotaline-induced pulmonary arterial hypertension by suppression of NF-κB-mediated autophagy activation. Life Sci. 2018; 208:87-95. DOI: 10.1016/j.lfs.2018.07.018. View

RUMSEY W, Abbott B, Bertelsen D, Mallamaci M, Hagan K, Nelson D . Adaptation to hypoxia alters energy metabolism in rat heart. Am J Physiol. 1999; 276(1):H71-80. DOI: 10.1152/ajpheart.1999.276.1.H71. View

Baarsma H, Bos S, Meurs H, Visser K, Smit M, Schols A . Pharmacological inhibition of GSK-3 in a guinea pig model of LPS-induced pulmonary inflammation: I. Effects on lung remodeling and pathology. Respir Res. 2013; 14:113. PMC: 4015129. DOI: 10.1186/1465-9921-14-113. View

Brown M, Neves E, Long G, Graber J, Gladish B, Wiseman A . High-intensity interval training, but not continuous training, reverses right ventricular hypertrophy and dysfunction in a rat model of pulmonary hypertension. Am J Physiol Regul Integr Comp Physiol. 2016; 312(2):R197-R210. PMC: 5504398. DOI: 10.1152/ajpregu.00358.2016. View

Oxborough D, Sharma S, Shave R, Whyte G, Birch K, Artis N . The right ventricle of the endurance athlete: the relationship between morphology and deformation. J Am Soc Echocardiogr. 2011; 25(3):263-71. DOI: 10.1016/j.echo.2011.11.017. View

Crestanello J, Doliba N, Babsky A, Doliba N, Niibori K, Osbakken M . Mitochondrial function during ischemic preconditioning. Surgery. 2002; 131(2):172-8. DOI: 10.1067/msy.2002.119490. View

Reiter R, Henry T, Traverse J . Preinfarction angina reduces infarct size in ST-elevation myocardial infarction treated with percutaneous coronary intervention. Circ Cardiovasc Interv. 2013; 6(1):52-8. PMC: 3607669. DOI: 10.1161/CIRCINTERVENTIONS.112.973164. View

10.

Alexander S, Kelly E, Mathie A, Peters J, Veale E, Armstrong J . THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets. Br J Pharmacol. 2019; 176 Suppl 1:S1-S20. PMC: 6844537. DOI: 10.1111/bph.14747. View

11.

Chang L, Sun C, Sheu J, Chiang C, Youssef A, Lee F . Cilostazol therapy attenuates monocrotaline-induced pulmonary arterial hypertension in rat model. Circ J. 2008; 72(5):825-31. DOI: 10.1253/circj.72.825. View

12.

Brookes C, Ravn H, White P, Moeldrup U, Oldershaw P, Redington A . Acute right ventricular dilatation in response to ischemia significantly impairs left ventricular systolic performance. Circulation. 1999; 100(7):761-7. DOI: 10.1161/01.cir.100.7.761. View

13.

Tian L, Neuber-Hess M, Mewburn J, Dasgupta A, Dunham-Snary K, Wu D . Ischemia-induced Drp1 and Fis1-mediated mitochondrial fission and right ventricular dysfunction in pulmonary hypertension. J Mol Med (Berl). 2017; 95(4):381-393. PMC: 5390778. DOI: 10.1007/s00109-017-1522-8. View

14.

McCormick L, Hoole S, White P, Read P, Axell R, Clarke S . Pre-treatment with glucagon-like Peptide-1 protects against ischemic left ventricular dysfunction and stunning without a detected difference in myocardial substrate utilization. JACC Cardiovasc Interv. 2015; 8(2):292-301. DOI: 10.1016/j.jcin.2014.09.014. View

15.

Srivastava D, Olson E . A genetic blueprint for cardiac development. Nature. 2000; 407(6801):221-6. DOI: 10.1038/35025190. View

16.

Shiraki H, Yoshikawa T, Anzai T, Negishi K, Takahashi T, Asakura Y . Association between preinfarction angina and a lower risk of right ventricular infarction. N Engl J Med. 1998; 338(14):941-7. DOI: 10.1056/NEJM199804023381402. View

17.

Giorgio V, von Stockum S, Antoniel M, Fabbro A, Fogolari F, Forte M . Dimers of mitochondrial ATP synthase form the permeability transition pore. Proc Natl Acad Sci U S A. 2013; 110(15):5887-92. PMC: 3625323. DOI: 10.1073/pnas.1217823110. View

18.

Phillips D, Aponte A, Covian R, Neufeld E, Yu Z, Balaban R . Homogenous protein programming in the mammalian left and right ventricle free walls. Physiol Genomics. 2011; 43(21):1198-206. PMC: 3217320. DOI: 10.1152/physiolgenomics.00121.2011. View

19.

Joshi S, Dhagia V, Gairhe S, Edwards J, McMurtry I, Gupte S . MicroRNA-140 is elevated and mitofusin-1 is downregulated in the right ventricle of the Sugen5416/hypoxia/normoxia model of pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol. 2016; 311(3):H689-98. PMC: 7199238. DOI: 10.1152/ajpheart.00264.2016. View

20.

Alzoubi A, Toba M, Abe K, ONeill K, Rocic P, Fagan K . Dehydroepiandrosterone restores right ventricular structure and function in rats with severe pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol. 2013; 304(12):H1708-18. DOI: 10.1152/ajpheart.00746.2012. View